Last reviewed · How we verify

NCT03156374

Timing Frozen Embryo Transfer by Following Two Different Methods

Completed NA Last updated 8 February 2021
What this trial tests

NA trial testing Test use in Fertility Disorders in 46 participants. Completed in 30 September 2019.

Timeline
30 April 2017
Primary endpoint
28 August 2019
30 September 2019

Quick facts

Lead sponsorSPD Development Company Limited
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment46
Start date30 April 2017
Primary completion28 August 2019
Estimated completion30 September 2019
Sites1 location across Australia

Drugs / interventions tested

Conditions studied

Sponsor

SPD Development Company Limited

Who can join

Adults 24 to 45, female only, with Fertility Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This proof of concept study is designed to determine the practicality of using home ovulation tests to enable optimum timing for transfer of frozen embryos in a natural menstrual cycle in comparison to the standard ultrasound and serum monitoring currently conducted by many IVF clinics.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Fertility Disorders

Currently open trials in the same condition.

Other SPD Development Company Limited trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03156374.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing